Within 30 days prior to admission, the ALR shall consult with the prospective resident’s healthcare practitioner regarding:
- (1) The prospective resident’s current medication profile, including a review of nonprescription drugs;
- (2) Possible adverse interactions;
- (3) Common expected or unexpected side effects; and
- (4) The potential that such medications have to act as chemical restraints.
History
June 24, 2000, D.C. Law 13-127, § 902, 47 DCR 2647